poisar

Stocks · News reference

GOP Congressman Slams JD Vance's Silence Over CDC's $1.24 Billion Pfizer COVID Vaccine Contracts: 'Why Isn’t He Speaking Out'

Jul 27, 2026, 12:01 PMNamrata Sen

Rep. Thomas Massie questions JD Vance's silence after the Trump CDC established a $1.24 Billion Pfizer COVID-19 vaccine contract.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

BNTXPFETSLA
Source
benzinga
Observed
Jul 27, 2026, 12:01 PM
Checked
Jul 27, 2026, 12:01 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 26, 2026, 1:46 PMResearchandmarkets.Com

    mRNA Therapeutics Market Outlook Report 2026-2035 Featuring Profiles of Arcturus Therapeutics, BioNTech, CureVac, Moderna, Providence Therapeutics, RNAimmune, Recode Therapeutics, and More

    The global mRNA therapeutics market (excluding COVID-19 applications) is projected to grow from USD 201 million in 2026 to USD 9.98 billion by 2035, with a 63% CAGR. Growth is driven by expanding oncology and rare disease pipelines, advances in lipid nanoparticle delivery, and strategic partnerships. However, challenges include tissue-selective delivery limitations, repeat-dose tolerability concerns, and regulatory complexities. Moderna and BioNTech dominate with approximately 70% of pipeline activity.

    Read original at globenewswire-inc
    MRNABNTXARCT
  2. Aug 26, 2026, 1:44 PMResearchandmarkets.Com

    $7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges

    The global mRNA vaccines market for non-COVID applications is projected to grow at a 109% compound annual growth rate from $9 million in 2026 to $7.04 billion by 2035. Market expansion is driven by advancing clinical pipelines, diversification into influenza, RSV, oncology and next-generation RNA technologies, with over 100 mRNA-based cancer candidates under investigation. Influenza is expected to become the leading indication by 2035, while North America remains the largest regional market.

    Read original at globenewswire-inc
    MRNABNTXPFESNY
  4. Aug 25, 2026, 4:46 PMBcc Research

    AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma Players

    Artificial intelligence is transforming blood cancer drug discovery and development, with over $2 billion in investment from major biotech and pharma companies. AI is reducing clinical trial timelines by up to 50%, improving patient selection, and enabling next-generation therapies like CAR-T and antibody-drug conjugates. North America leads with 40% of global market share, while Asia-Pacific emerges as a significant growth region.

    Read original at globenewswire-inc
    MRKRHHBYBMYCELGRNVS
  6. Aug 27, 2026, 6:07 PMRyan Vanzo

    Tesla Announces Semi Event For September 24. Here's What Investors Need to Know

    Tesla is hosting an invite-only Semi truck event on September 24 to celebrate its new factory and showcase production scaling. While Semi sales have been disappointing since 2017, recent momentum from orders like Einride's 500-unit purchase shows potential. However, significant growth depends on autonomous trucking adoption, which McKinsey projects won't take off until 2032. Key barriers include high upfront costs ($350,000 vs. $165,000 for diesel trucks), operator inexperience, and unpredictable operating costs.

    Read original at the-motley-fool
    TSLA